Literature DB >> 36061581

Pediatric Respiratory Virus Infections During the COVID-19 Pandemic in a Region Without Active Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Circulation.

Sosuke Kakee1, Yoichi Mino1, Keisuke Okuno1, Daisuke Kawaba1, Atsushi Maejima1, Noriyuki Namba1.   

Abstract

Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were not prevalent in Yonago and its vicinity during autumn 2020, and the relative frequencies of pathogen-induced respiratory infections during this period are unclear.
Methods: We collected 109 nasopharyngeal swabs from 93 pediatric patients who visited Tottori University Hospital between October 1, 2020, and March 31, 2021. These samples were comprehensively tested for 18 pathogens with the FilmArray® respiratory panel test (v2.1) using nested real-time polymerase chain reaction, and the frequency of pathogens detected per month was calculated. In addition, we compared the duration of fever and the blood test results of patients infected with each pathogen or multiple pathogens.
Results: Of the 109 samples, 42 were obtained from female patients and 67 from male patients (median age, 3 years; range, 0-15 years). Overall, 62 patients (56.9%) had a fever ≥ 38 °C at the time of examination, and the median duration of fever ≥ 38 °C was 2 days (1-12). During the study period, the highest number of samples (22) were collected in November 2020. Among samples that tested positive, the most common pathogens were rhino/enteroviruses (52 samples; 76.5%), followed by adenoviruses (7 samples; 10.3%), coronavirus NL63 (6 samples; 8.8%), coronavirus OC43, parainfluenza virus type 1, and parainfluenza virus type 2 (1 sample each; 1.5% each). The duration of fever was significantly longer in adenovirus-infected patients than in patients infected with other viruses (P < 0.05). Hemoglobin and sodium levels were also significantly lower among the adenovirus-infected patients. However, these variations were mostly within the normal range. No clinically meaningful differences were found between rhino/enterovirus-infected and non-rhino/enterovirus-infected cases, between coronavirus NL63-infected and non-coronavirus NL63-infected cases, and between cases with multiple- and single-pathogen infections.
Conclusion: Rhino/enteroviruses were the most common viruses causing respiratory tract infections in areas without endemic SARS-CoV-2. ©2022 Tottori University Medical Press.

Entities:  

Keywords:  adenovirus; common coronavirus; respiratory panel test; rhino/enterovirus; severe acute respiratory syndrome coronavirus 2

Year:  2022        PMID: 36061581      PMCID: PMC9419221          DOI: 10.33160/yam.2022.08.011

Source DB:  PubMed          Journal:  Yonago Acta Med        ISSN: 0513-5710            Impact factor:   1.371


  33 in total

1.  Adenoviral diseases in children: a study of 105 hospital cases.

Authors:  O Ruuskanen; O Meurman; H Sarkkinen
Journal:  Pediatrics       Date:  1985-07       Impact factor: 7.124

2.  Virucidal activity of alcohol-based hand rub disinfectants.

Authors:  Atsuo Iwasawa; Yoshimi Niwano; Masahiro Kohno; Masahiko Ayaki
Journal:  Biocontrol Sci       Date:  2012-03       Impact factor: 0.982

3.  Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study.

Authors:  Anchi Wu; Valia T Mihaylova; Marie L Landry; Ellen F Foxman
Journal:  Lancet Microbe       Date:  2020-09-05

4.  Cytokines in adenoviral disease in children: association of interleukin-6, interleukin-8, and tumor necrosis factor alpha levels with clinical outcome.

Authors:  A S Mistchenko; R A Diez; A L Mariani; J Robaldo; A F Maffey; G Bayley-Bustamante; S Grinstein
Journal:  J Pediatr       Date:  1994-05       Impact factor: 4.406

5.  Increased risk of rhinovirus infection in children during the coronavirus disease-19 pandemic.

Authors:  Emi Takashita; Chiharu Kawakami; Tomoko Momoki; Miwako Saikusa; Kouhei Shimizu; Hiroki Ozawa; Makoto Kumazaki; Shuzo Usuku; Nobuko Tanaka; Ichiro Okubo; Hiroko Morita; Shiho Nagata; Shinji Watanabe; Hideki Hasegawa; Yoshihiro Kawaoka
Journal:  Influenza Other Respir Viruses       Date:  2021-03-14       Impact factor: 4.380

Review 6.  Coronavirus envelope protein: current knowledge.

Authors:  Dewald Schoeman; Burtram C Fielding
Journal:  Virol J       Date:  2019-05-27       Impact factor: 4.099

7.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.

Authors: 
Journal:  Nat Microbiol       Date:  2020-03-02       Impact factor: 17.745

Review 8.  Upper respiratory tract infections.

Authors:  N Jain; R Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2001-12       Impact factor: 1.967

9.  Different SARS-CoV-2 variants, same prevention strategies.

Authors:  Tafadzwa Dzinamarira; Grant Murewanhema; Godfrey Musuka
Journal:  Public Health Pract (Oxf)       Date:  2021-12-11

10.  Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2.

Authors:  Hannah M Creager; Barbara Cabrera; Andy Schnaubelt; Jesse L Cox; Allison M Cushman-Vokoun; Salika M Shakir; Keith D Tardif; Meei-Li Huang; Keith R Jerome; Alexander L Greninger; Daria Drobysheva; Usha Spaulding; Margarita Rogatcheva; Kevin M Bourzac; S H Hinrichs; M J Broadhurst; P D Fey
Journal:  J Clin Virol       Date:  2020-07-06       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.